In the hypercompetitive world of commercial real estate investment ... So if you aren’t using a vertical-specific deal, pipeline, and relationship management system, your key players aren’t getting ...

Brookline analyst Leah Rush Cann initiated coverage of Exelixis (EXEL) with a Buy rating. The firm anticipates Exelixis will continue to ...

The firm anticipates Exelixis will continue to develop its commercial drugs ... sees potential from the company’s earlier stage pipeline. Based on its expectation that Exelixis will grow ...